DZD9008 PK Study in Hepatic Impairment Subjects

Clinical trial NCT06084104 · COMPLETED

Trial details

NCT number: NCT06084104
Sponsor: Dizal Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2023-10-17
Primary completion: 2024-06-12
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.